Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis.

Goldstein RH, Reagan MR, Anderson K, Kaplan DL, Rosenblatt M.

Cancer Res. 2010 Dec 15;70(24):10044-50. doi: 10.1158/0008-5472.CAN-10-1254.

2.
3.

Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.

Houghton J, Li H, Fan X, Liu Y, Liu JH, Rao VP, Poutahidis T, Taylor CL, Jackson EA, Hewes C, Lyle S, Cerny A, Bowen G, Cerny J, Moore N, Kurt-Jones EA, Erdman SE.

Stem Cells Dev. 2010 Aug;19(8):1153-66. doi: 10.1089/scd.2009.0439.

4.

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA.

Nature. 2007 Oct 4;449(7162):557-63.

PMID:
17914389
5.

Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity.

Rappa G, Mercapide J, Lorico A.

Am J Pathol. 2012 Jun;180(6):2504-15. doi: 10.1016/j.ajpath.2012.02.020. Epub 2012 Apr 27.

6.

Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.

Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R, Wicha MS.

Cancer Res. 2011 Jan 15;71(2):614-24. doi: 10.1158/0008-5472.CAN-10-0538. Epub 2011 Jan 11. Erratum in: Cancer Res. 2011 Mar 15;71(6):2407.

7.

GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.

Peng Y, Li Z, Li Z.

Biochem Biophys Res Commun. 2013 Nov 1;440(4):558-63. doi: 10.1016/j.bbrc.2013.09.108. Epub 2013 Oct 7.

PMID:
24113381
8.

Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.

Ritter E, Perry A, Yu J, Wang T, Tang L, Bieberich E.

Ann Surg. 2008 Feb;247(2):310-4. doi: 10.1097/SLA.0b013e31816401d5.

PMID:
18216538
9.

Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells.

Zhou Y, Zuo D, Wang M, Zhang Y, Yu M, Yang J, Yao Z.

Genes Cells. 2014 Sep;19(9):676-91. doi: 10.1111/gtc.12168. Epub 2014 Aug 6.

10.

Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.

Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.

Breast Cancer Res Treat. 2011 Apr;126(2):373-84. doi: 10.1007/s10549-010-0921-0. Epub 2010 May 13.

PMID:
20464481
11.

Parathyroid hormone-related protein and bone metastases.

Guise TA.

Cancer. 1997 Oct 15;80(8 Suppl):1572-80. Review.

PMID:
9362424
12.

Mesenchymal/stromal gene expression signature relates to basal-like breast cancers, identifies bone metastasis and predicts resistance to therapies.

Marchini C, Montani M, Konstantinidou G, Orrù R, Mannucci S, Ramadori G, Gabrielli F, Baruzzi A, Berton G, Merigo F, Fin S, Iezzi M, Bisaro B, Sbarbati A, Zerani M, Galiè M, Amici A.

PLoS One. 2010 Nov 30;5(11):e14131. doi: 10.1371/journal.pone.0014131.

13.

Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.

Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.

Oncogene. 2002 Jan 3;21(1):108-18.

14.

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102. doi: 10.1186/1471-2407-9-102.

15.

Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.

Moreau JE, Anderson K, Mauney JR, Nguyen T, Kaplan DL, Rosenblatt M.

Cancer Res. 2007 Nov 1;67(21):10304-8.

16.

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

Boucharaba A, Serre CM, Grès S, Saulnier-Blache JS, Bordet JC, Guglielmi J, Clézardin P, Peyruchaud O.

J Clin Invest. 2004 Dec;114(12):1714-25.

17.

Breast cancer metastasis in a human bone NOD/SCID mouse model.

Yang W, Lam P, Kitching R, Kahn HJ, Yee A, Aubin JE, Seth A.

Cancer Biol Ther. 2007 Aug;6(8):1289-94. Epub 2007 May 25.

PMID:
17704641
18.

Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.

Sung SY, Liao CH, Wu HP, Hsiao WC, Wu IH, Jinpu, Yu, Lin SH, Hsieh CL.

PLoS One. 2013 Aug 19;8(8):e71637. doi: 10.1371/journal.pone.0071637. eCollection 2013.

19.

Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.

Xia TS, Wang GZ, Ding Q, Liu XA, Zhou WB, Zhang YF, Zha XM, Du Q, Ni XJ, Wang J, Miao SY, Wang S.

Breast Cancer Res Treat. 2012 Apr;132(2):471-86. doi: 10.1007/s10549-011-1496-0. Epub 2011 Jun 3.

PMID:
21638054
20.

Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.

Chaturvedi P, Gilkes DM, Wong CC; Kshitiz, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL.

J Clin Invest. 2013 Jan;123(1):189-205. doi: 10.1172/JCI64993. Epub 2012 Dec 17. Erratum in: J Clin Invest. 2013 Mar 1;123(3):1402.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk